| Literature DB >> 22642704 |
Sareth Rith1, Punnaporn Netrabukkana, San Sorn, Elizabeth Mumford, Channa Mey, Davun Holl, Flavie Goutard, Bunthin Y, Stan Fenwick, Ian Robertson, François Roger, Philippe Buchy.
Abstract
BACKGROUND: This study was conducted from 2006 to 2010 and investigated the seroprevalence of influenza A viruses in Cambodian pigs, including human H1N1, H3N2, 2009 pandemic H1N1 (A(H1N1)pdm09), and highly pathogenic avian H5N1 influenza A viruses.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22642704 PMCID: PMC5779822 DOI: 10.1111/j.1750-2659.2012.00382.x
Source DB: PubMed Journal: Influenza Other Respir Viruses ISSN: 1750-2640 Impact factor: 4.380
Figure 1Source of samples and the testing regime.
Reference viruses used in the serological tests
| Influenza virus | Year of sampling | Assay |
|---|---|---|
| A/New Caledonia/20/99 (H1N1) | 2006–2007 | HI |
| A/Wisconsin/67/2005 (H3N2) | 2006–2007 | HI |
| A/Brisbane/59/2007 (H1N1) | 2008 | HI |
| A/Brisbane/10/2007 (H3N2) | 2008 | HI |
| A/Brisbane/59/2007 (H1N1) | 2009–2010* | HI |
| A/Perth/16/2009 (H3N2) | 2009–2010 | HI |
| A/California/7/2009 (H1N1) | 2009–2010 | HI |
| A/Cambodia/Q0321176/2006 (H5N1) | 2006 | HI, MN |
| A/Cambodia/S1211394/2008 (H5N1) | 2008 | HI, MN |
| A/Cambodia/T1218159/2009 (H5N1) | 2009 | HI, MN |
| A/Cambodia/U0417030/2010 (H5N1) | 2010 | HI, MN |
HI, hemagglutination inhibition assay; MN, microneutralization assay.
H3N2 virus circulated in human population during all the duration of the study.
*Seasonal H1N1 viruses circulated in Cambodia every year from 2006 until August 2009 when they were progressively replaced by H1N1pdm 2009 virus. Because the pig sera collected early in 2010 could reflect an exposition that occur in 2009, H1N1 virus was included in the panel also in 2010.
Annual seroprevalence to each influenza A virus subtypes tested (n = 1147)
| Year | No. of sera | HI positivity rate to different influenza virus antigens | |||||||
|---|---|---|---|---|---|---|---|---|---|
| H1(%) | 95%CI | H3(%) | 95%CI | A(H1N1) pdm09(%) | 95%CI | H5(%) | 95%CI | ||
| 2006 | 393 | 5·6 | 3·5–8·4 | 2·3 | 1·1–4·3 | NT | – | 0* | 0·0–12·8 |
| 2007 | 113 | 2·7 | 0·6–7·6 | 0·0 | 0·0–3·2 | NT | – | NT | – |
| 2008 | 269 | 46·5 | 40·4–52·6 | 33·8 | 28·2–39·8 | NT | – | 0* | 0·0–7·0 |
| 2009 | 36 | 19·4 | 8·2–36·0 | 13·9 | 4·7–29·5 | 0·0 | 0·0–9·7 | 0* | 0·0–9·7 |
| 2010 | 336 | 12·5 | 9·2–16·5 | 2·4 | 1·0–4·6 | 25·6 | 21·0–30·6 | 0* | 0·0–9·7 |
*Only a subset of the samples were tested for antibodies against H5N1 virus.
NT, not tested; HI, hemagglutination inhibition assay.
HI titers to three different influenza subtypes
| Antibody titers | Different influenza subtypes | ||
|---|---|---|---|
| H1N1 | H3N2 | A(H1N1)pdm09 | |
| Range | 0–320 | 0–640 | 0–640 |
| Mean ± SD | 16·2 ± 29·4 | 10·7 ± 26·7 | 26·5 ± 59·4 |
| No. of sera tested | 1147 | 1147 | 372 |
HI, hemagglutination inhibition assay.
Seroprevalence to H1N1, H3N2 viruses in two age groups (n = 538)
| Age group | Seropositivity: number positive/number tested (%) | |||
|---|---|---|---|---|
| H1N1 | 95%CI | H3N2 | 95%CI | |
| ≤4 month | 22/340 (6·5) | 4·1–9·6 | 7/340 (2·1) | 0·8–4·2 |
| >4 month | 6/198 (3·0) | 1·1–6·5 | 3/198 (1·5) | 0·3–4·4 |
|
| 0·11 | 0·75 | ||
aStatistical analysis for differences of seropositivity between different age groups; P < 0·05 is considered statistically significant.
Figure 2Seroprevalences against H1N1, H3N2, and A(H1N1)pdm09 viruses, respectively, in various provinces in Cambodia.